When regulation disrupts treatment: controlled-substance policies, continuity of chronic disease care, and health equity

CONCLUSION: Controlled-substance policy should be evaluated using a dual public health standard: prevention of misuse and diversion and preservation of timely access to medically necessary treatment. The patient experiences identified in MINDSET 2.0 suggest that regulatory requirements can interact with insurance rules, pharmacy practices, medication availability, transportation, employment, and other structural factors to create cumulative barriers to treatment continuity. Medication- and…

via https://pubmed.ncbi.nlm.nih.gov/43065487/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20261122020804&v=2.20.1


Post a Comment

Your email is never published nor shared. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>